ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT06878404

Public ClinicalTrials.gov record NCT06878404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants With Active Psoriatic Arthritis

Study identification

NCT ID
NCT06878404
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
552 participants

Conditions and interventions

Interventions

  • Active reference comparator Drug
  • Icotrokinra Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 20, 2025
Primary completion
May 26, 2026
Completion
Feb 3, 2028
Last update posted
Apr 12, 2026

2025 – 2028

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Arthritis and Rheumatism Associates ARA Jonesboro Jonesboro Arkansas 72401
Omega Research Consultants DeBary Florida 32713
Integral Rheumatology And Immunology Specialists Plantation Florida 33324
Clinical Research of West Florida Tampa Florida 33606
Willow Rheumatology and Wellness PLLC Willowbrook Illinois 60527
Joint and Muscle Research Institute Charlotte North Carolina 28204
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Arthritis and Rheumatology Research Institute Allen Texas 75013
Naiara Alvarez MD Integrative Rheumatology of South TX Harlingen Texas 78550

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 146 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06878404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06878404 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →